These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 32948353)

  • 1. The role of RHOT1 and RHOT2 genetic variation on Parkinson disease risk and onset.
    Periñán MT; Gómez-Garre P; Blauwendraat C; Mir P; Bandres-Ciga S;
    Neurobiol Aging; 2021 Jan; 97():144.e1-144.e3. PubMed ID: 32948353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations in
    Grossmann D; Berenguer-Escuder C; Bellet ME; Scheibner D; Bohler J; Massart F; Rapaport D; Skupin A; Fouquier d'Hérouël A; Sharma M; Ghelfi J; Raković A; Lichtner P; Antony P; Glaab E; May P; Dimmer KS; Fitzgerald JC; Grünewald A; Krüger R
    Antioxid Redox Signal; 2019 Dec; 31(16):1213-1234. PubMed ID: 31303019
    [No Abstract]   [Full Text] [Related]  

  • 3. Generation of two induced pluripotent stem cell lines and the corresponding isogenic controls from Parkinson's disease patients carrying the heterozygous mutations c.815G > A (p.R272Q) or c.1348C > T (p.R450C) in the RHOT1 gene encoding Miro1.
    Chemla A; Arena G; Onal G; Walter J; Berenguer-Escuder C; Grossmann D; Grünewald A; Schwamborn JC; Krüger R
    Stem Cell Res; 2023 Sep; 71():103145. PubMed ID: 37364399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of two induced pluripotent stem cell lines and the corresponding isogenic controls from Parkinson's disease patients carrying the heterozygous mutations c.1290A > G (p.T351A) or c.2067A > G (p.T610A) in the RHOT1 gene encoding Miro1.
    Chemla A; Arena G; Saraiva C; Berenguer-Escuder C; Grossmann D; Grünewald A; Klein C; Seibler P; Schwamborn JC; Krüger R
    Stem Cell Res; 2023 Jun; 69():103085. PubMed ID: 37003181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rare genetic variation in mitochondrial pathways influences the risk for Parkinson's disease.
    Gaare JJ; Nido GS; Sztromwasser P; Knappskog PM; Dahl O; Lund-Johansen M; Maple-Grødem J; Alves G; Tysnes OB; Johansson S; Haugarvoll K; Tzoulis C
    Mov Disord; 2018 Oct; 33(10):1591-1600. PubMed ID: 30256453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial transport proteins RHOT1 and RHOT2 serve as docking sites for PRKN-mediated mitophagy.
    Safiulina D; Kuum M; Choubey V; Hickey MA; Kaasik A
    Autophagy; 2019 May; 15(5):930-931. PubMed ID: 30806158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Large-scale pathway specific polygenic risk and transcriptomic community network analysis identifies novel functional pathways in Parkinson disease.
    Bandres-Ciga S; Saez-Atienzar S; Kim JJ; Makarious MB; Faghri F; Diez-Fairen M; Iwaki H; Leonard H; Botia J; Ryten M; Hernandez D; Gibbs JR; Ding J; Gan-Or Z; Noyce A; Pihlstrom L; Torkamani A; Soltis AR; Dalgard CL; ; Scholz SW; Traynor BJ; Ehrlich D; Scherzer CR; Bookman M; Cookson M; Blauwendraat C; Nalls MA; Singleton AB;
    Acta Neuropathol; 2020 Sep; 140(3):341-358. PubMed ID: 32601912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic analysis of CHCHD2 and CHCHD10 in Italian patients with Parkinson's disease.
    Rubino E; Brusa L; Zhang M; Boschi S; Govone F; Vacca A; Gai A; Pinessi L; Lopiano L; Rogaeva E; Rainero I
    Neurobiol Aging; 2017 May; 53():193.e7-193.e8. PubMed ID: 28108040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of evidence for association of UQCRC1 with Parkinson's disease in Europeans.
    Senkevich K; Bandres-Ciga S; Gan-Or Z; Krohn L;
    Neurobiol Aging; 2021 May; 101():297.e1-297.e4. PubMed ID: 33248804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variants in Miro1 Cause Alterations of ER-Mitochondria Contact Sites in Fibroblasts from Parkinson's Disease Patients.
    Berenguer-Escuder C; Grossmann D; Massart F; Antony P; Burbulla LF; Glaab E; Imhoff S; Trinh J; Seibler P; Grünewald A; Krüger R
    J Clin Med; 2019 Dec; 8(12):. PubMed ID: 31888276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of R272Q, S156A and K572R RHOT1/Miro1 point mutations in iPSCs from a healthy individual using FACS-assisted CRISPR/Cas9 genome editing.
    Schwarz L; Casadei N; Fitzgerald JC
    Stem Cell Res; 2021 Aug; 55():102469. PubMed ID: 34359002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Destructive cellular paths underlying familial and sporadic Parkinson disease converge on mitophagy.
    Wang X
    Autophagy; 2017; 13(11):1998-1999. PubMed ID: 28598236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parkinson Disease from Mendelian Forms to Genetic Susceptibility: New Molecular Insights into the Neurodegeneration Process.
    Karimi-Moghadam A; Charsouei S; Bell B; Jabalameli MR
    Cell Mol Neurobiol; 2018 Aug; 38(6):1153-1178. PubMed ID: 29700661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired mitochondrial-endoplasmic reticulum interaction and mitophagy in Miro1-mutant neurons in Parkinson's disease.
    Berenguer-Escuder C; Grossmann D; Antony P; Arena G; Wasner K; Massart F; Jarazo J; Walter J; Schwamborn JC; Grünewald A; Krüger R
    Hum Mol Genet; 2020 May; 29(8):1353-1364. PubMed ID: 32280985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polygenic Resilience Modulates the Penetrance of Parkinson Disease Genetic Risk Factors.
    Liu H; Dehestani M; Blauwendraat C; Makarious MB; Leonard H; Kim JJ; Schulte C; Noyce A; Jacobs BM; Foote I; Sharma M; ; Nalls M; Singleton A; Gasser T; Bandres-Ciga S
    Ann Neurol; 2022 Aug; 92(2):270-278. PubMed ID: 35599344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic Screening of the Mitochondrial Rho GTPases MIRO1 and MIRO2 in Parkinson's Disease.
    Anvret A; Ran C; Westerlund M; Sydow O; Willows T; Olson L; Galter D; Belin AC
    Open Neurol J; 2012; 6():1-5. PubMed ID: 22496713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of association of mortalin (HSPA9) and other mitochondria-related genes with risk of Parkinson's and Alzheimer's diseases.
    Chung SJ; Kim MJ; Ryu HS; Kim J; Kim YJ; Kim K; You S; Kim SY; Lee JH
    Neurobiol Aging; 2017 Jan; 49():215.e9-215.e10. PubMed ID: 28340952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The GBA-370Rec Parkinson's disease risk haplotype harbors a potentially pathogenic variant in the mitochondrial gene SLC25A44.
    Goldstein O; Gana-Weisz M; Attar R; Bar-Shira A; Lederkremer M; Shiner T; Thaler A; Mirelman A; Giladi N; Orr-Urtreger A
    Mol Genet Metab; 2021 May; 133(1):109-112. PubMed ID: 33762134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic Analysis of Prosaposin, the Lysosomal Storage Disorder Gene in Parkinson's Disease.
    Chen YP; Gu XJ; Ou RW; Zhang LY; Hou YB; Liu KC; Cao B; Wei QQ; Song W; Zhao B; Wu Y; Cheng JQ; Shang HF
    Mol Neurobiol; 2021 Apr; 58(4):1583-1592. PubMed ID: 33219486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondria: A Therapeutic Target for Parkinson's Disease?
    Luo Y; Hoffer A; Hoffer B; Qi X
    Int J Mol Sci; 2015 Sep; 16(9):20704-30. PubMed ID: 26340618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.